The global Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) market is poised for strong growth from 2025 to 2034, driven by the increasing prevalence of cardiovascular diseases (CVDs), advancements in AI-integrated imaging systems, and rising adoption in clinical decision-making and interventional cardiology.
These imaging technologies are critical in assessing vessel morphology, detecting plaque, guiding stent placement, and minimizing procedure-related complications.
North America held ~48% of the global market in 2024.
Asia Pacific is projected to grow at the fastest rate through 2034.
The IVUS segment dominated with ~58% market share in 2024.
The OCT segment is expected to grow at >8% CAGR during the forecast period.
By product, imaging catheters led the market in 2024.
Imaging consoles/systems are projected to be the fastest-growing segment moving forward.
About: A leading Dutch multinational in healthcare technology.
Products: IVUS systems (Eagle Eye Platinum catheter, Core Mobile system), and integrated imaging platforms.
Market Cap: Approx. $22 billion (as of 2025).
Strength: Strong innovation in intravascular imaging and global reach.
About: U.S.-based healthcare giant known for cardiovascular and diagnostic products.
Products: Optis™ Integrated OCT Imaging System, Dragonfly™ Imaging Catheters.
Market Cap: Around $170 billion (2025).
Strength: Extensive clinical adoption and product development for coronary imaging.
About: Major medical device manufacturer headquartered in the U.S.
Products: Polaris Multi-Modality Guidance System, OptiCross IVUS catheter.
Market Cap: Around $90 billion.
Strength: Focus on minimally invasive interventions and advanced image guidance.
About: A leading Japanese medical technology company.
Products: Lunawave IVUS System, Micro Guidewires.
Market Cap: Around $25 billion.
Strength: Strong in Asia-Pacific, extensive product pipeline in cardiology.
About: U.S.-based, part of the Italian Bracco Imaging group.
Products: HDi® HD IVUS system, Kodama® catheter.
Market Cap: Privately held (Bracco Group estimated value ~$2 billion).
Strength: Known for high-definition IVUS imaging solutions.
About: A U.S. company specializing in intravascular imaging, acquired by Nipro.
Products: TVC Imaging System, combining IVUS + NIRS (near-infrared spectroscopy).
Market Cap (Nipro): Approx. $4 billion.
Strength: Dual imaging technology and coronary plaque characterization.
About: Canadian innovator in hybrid intravascular imaging.
Products: Novasight Hybrid System (IVUS + OCT).
Market Cap: Private company.
Strength: First-in-class hybrid IVUS-OCT imaging in a single catheter.
About: A subsidiary of Canon Inc., Japan.
Products: Angiography and IVUS solutions (formerly Toshiba Medical).
Market Cap (Canon Inc.): Approx. $30 billion.
Strength: Integration of imaging modalities and AI capabilities.
About: U.S.-based medtech leader, recently spun off from GE.
Products: Developing OCT and vascular imaging platforms.
Market Cap: Around $35 billion.
Strength: Expanding portfolio with investments in cardiovascular imaging.
About: German medtech company with global operations.
Products: Advanced imaging platforms, with partnerships for IVUS/OCT.
Market Cap: Approx. $60 billion.
Strength: AI-enabled diagnostics and hospital integration.
About: U.S.-based AI startup focusing on ultrasound.
Products: AI-guided cardiac ultrasound systems.
Market Cap: Acquired by GE HealthCare in 2023.
Strength: AI innovations for automated intravascular imaging analysis.
About: Leading Chinese manufacturer of minimally invasive surgical devices.
Products: Exploring entry into cardiovascular imaging market.
Market Cap: Approx. $1.2 billion.
Strength: Rapidly expanding product innovation in Asia.
About: Indian medical devices firm with global outreach.
Products: Imaging-enabled interventional cardiology systems.
Market Cap: Private company.
Strength: Strong R&D and growing footprint in emerging markets.
About: One of the world’s largest medical device firms.
Products: Coronary imaging tools, acquisition strategy for tech expansion.
Market Cap: Approx. $100 billion.
Strength: Global leader in CVD treatment with investment in imaging tech.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
The market is growing due to rising cases of cardiovascular diseases, innovations in imaging technology, and demand for precision-guided interventions using IVUS and OCT.
North America holds the largest market share (~48% in 2024), driven by advanced healthcare infrastructure and high adoption rates.
The OCT segment is expected to register a CAGR of over 8% during 2025–2034 due to its high-resolution imaging capabilities.
AI is being integrated to improve image analysis, automate plaque detection, and guide stent placement, leading to better procedural outcomes.
Yes, companies like Conavi Medical have developed systems that combine IVUS and OCT for comprehensive intravascular imaging in a single procedure.
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5894
Asia-Pacific is poised to become the fastest-growing region in the small-scale bioreactors market over the coming years, driven by several… Read More
North America continues to dominate the global neurostimulation devices market, holding a significant 60% share in 2024. Several key factors… Read More
AAVnerGene Inc., an innovative biotech company based in Rockville, MD, known for its cutting-edge AAV tissue-targeted delivery and manufacturing technologies,… Read More
Jiangsu Hengrui Pharmaceuticals Co., Ltd. and IDEAYA Biosciences, Inc. are set to showcase their groundbreaking research at the IASLC 2025… Read More
QIAGEN has launched its new QIAseq xHYB long-read panels, a cutting-edge solution designed to explore the complexities of genomically diverse… Read More
Kyoto, Japan July 2025 A groundbreaking collaboration has been formed between Kansai Startup Academia Coalition (KSAC), led by Kyoto University,… Read More